{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:14:37Z","timestamp":1787786077426,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37 CA248289"],"award-info":[{"award-number":["R37 CA248289"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA255574"],"award-info":[{"award-number":["K08 CA255574"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37 CA304010"],"award-info":[{"award-number":["R37 CA304010"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5T32 CA 9501-34"],"award-info":[{"award-number":["5T32 CA 9501-34"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69984-y","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:49:22Z","timestamp":1772113762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-2903","authenticated-orcid":false,"given":"Paul B.","family":"Romesser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Bercz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-959X","authenticated-orcid":false,"given":"Janet","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-6032","authenticated-orcid":false,"given":"Angela","family":"Adames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa K.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-024X","authenticated-orcid":false,"given":"Yu-Jui","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Reyngold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-5454","authenticated-orcid":false,"given":"Rona","family":"Yaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A.","family":"Roth O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Cuaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Zinovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Olinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Ravella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1378-7662","authenticated-orcid":false,"given":"Jeanine","family":"Lisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wini","family":"Zambare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8003-358X","authenticated-orcid":false,"given":"Vasily N.","family":"Aushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-8273","authenticated-orcid":false,"given":"Samuel","family":"Rivero-Hinojosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-3053","authenticated-orcid":false,"given":"Adham","family":"Jurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-5232","authenticated-orcid":false,"given":"Minetta C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-7091","authenticated-orcid":false,"given":"Abraham","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vonetta","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Pappou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3047-2303","authenticated-orcid":false,"given":"Neil H.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-2112","authenticated-orcid":false,"given":"Philip B.","family":"Paty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-7984","authenticated-orcid":false,"given":"Martin R.","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Marcet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2451-0948","authenticated-orcid":false,"given":"Julio","family":"Garcia-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-8477","authenticated-orcid":false,"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-5456","authenticated-orcid":false,"given":"J. Joshua","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"69984_CR1","doi-asserted-by":"crossref","unstructured":"Nigro, N. D., Vaitkevicius, V. K. & Considine, B. Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis. Colon Rectum 17, 354\u2013356 (1974).","DOI":"10.1007\/BF02586980"},{"key":"69984_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert, D. et al. Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J. Clin. Oncol. 30, 1941\u20131948 (2012).","journal-title":"J. Clin. Oncol."},{"key":"69984_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James, R. D. et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol. 14, 516\u2013524 (2013).","journal-title":"Lancet Oncol."},{"key":"69984_CR4","unstructured":"Oncology:, N. C. P. G. i. Anal Carcinoma, Version 5., https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/anal.pdf."},{"key":"69984_CR5","doi-asserted-by":"publisher","unstructured":"Rosen, R. et al. Oncologic outcomes of salvage abdominoperineal resection for anal squamous cell carcinoma initially managed with chemoradiation. J. Clin. Med. 13, https:\/\/doi.org\/10.3390\/jcm13082156 (2024).","DOI":"10.3390\/jcm13082156"},{"key":"69984_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ijrobp.2024.10.007","volume":"121","author":"DA Roth O\u2019Brien","year":"2025","unstructured":"Roth O\u2019Brien, D. A. et al. Clinical outcomes, patterns of failure, and salvage therapies of a large modern cohort of patients with anal squamous cell carcinoma treated with definitive-intent intensity-modulated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 121, 951\u2013962 (2025).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"69984_CR7","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","volume":"386","author":"J Tie","year":"2022","unstructured":"Tie, J. et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N. Engl. J. Med. 386, 2261\u20132272 (2022).","journal-title":"N. Engl. J. Med."},{"key":"69984_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s41591-025-03579-w","volume":"31","author":"J Tie","year":"2025","unstructured":"Tie, J. et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nat. Med. 31, 1509\u20131518 (2025).","journal-title":"Nat. Med."},{"key":"69984_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.ccell.2023.09.007","volume":"41","author":"Y Pan","year":"2023","unstructured":"Pan, Y. et al. Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients. Cancer Cell 41, 1763\u20131773 e1764 (2023).","journal-title":"Cancer Cell"},{"key":"69984_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/1078-0432.CCR-22-3526","volume":"29","author":"M Lapin","year":"2023","unstructured":"Lapin, M. et al. Comprehensive ctDNA measurements improve prediction of clinical outcomes and enable dynamic tracking of disease progression in advanced pancreatic cancer. Clin. Cancer Res. 29, 1267\u20131278 (2023).","journal-title":"Clin. Cancer Res."},{"key":"69984_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/JCO.23.00954","volume":"42","author":"K Han","year":"2024","unstructured":"Han, K. et al. Clinical validation of Human Papilloma Virus circulating tumor DNA for early detection of residual disease after chemoradiation in cervical cancer. J. Clin. Oncol. 42, 431\u2013440 (2024).","journal-title":"J. Clin. Oncol."},{"key":"69984_CR12","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1158\/1078-0432.CCR-18-0922","volume":"24","author":"L Cabel","year":"2018","unstructured":"Cabel, L. et al. Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma. Clin. Cancer Res. 24, 5767\u20135771 (2018).","journal-title":"Clin. Cancer Res."},{"key":"69984_CR13","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-18-2984","volume":"25","author":"A Bernard-Tessier","year":"2019","unstructured":"Bernard-Tessier, A. et al. Clinical validity of HPV circulating tumor DNA in advanced anal carcinoma: an Ancillary Study to the epitopes-HPV02 trial. Clin. Cancer Res. 25, 2109\u20132115 (2019).","journal-title":"Clin. Cancer Res."},{"key":"69984_CR14","doi-asserted-by":"publisher","unstructured":"Lefevre, A. C. et al. The clinical value of measuring circulating HPV DNA during chemo-radiotherapy in squamous cell carcinoma of the anus. Cancers 13, https:\/\/doi.org\/10.3390\/cancers13102451 (2021).","DOI":"10.3390\/cancers13102451"},{"key":"69984_CR15","doi-asserted-by":"publisher","unstructured":"Mazurek, A. M. et al. Circulating HPV16 DNA in blood plasma as prognosticator and early indicator of cancer recurrence in radio-chemotherapy for anal cancer. Cancers 15, https:\/\/doi.org\/10.3390\/cancers15030867 (2023).","DOI":"10.3390\/cancers15030867"},{"key":"69984_CR16","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1158\/1078-0432.CCR-24-2575","volume":"31","author":"VK Morris","year":"2025","unstructured":"Morris, V. K. et al. Time dependency for human papillomavirus circulating tumor DNA detection after chemoradiation as a prognostic biomarker for localized anal cancer. Clin. Cancer Res. 31, 2399\u20132405 (2025).","journal-title":"Clin. Cancer Res."},{"key":"69984_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QAI.0000000000003231","volume":"94","author":"G Ellsworth","year":"2023","unstructured":"Ellsworth, G. et al. High specificity of HPV cell-free DNA tests in persons with HIV for the detection of HPV-related cancer. J. Acquir. Immune Defic. Syndr. 94, 73\u201381 (2023).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"69984_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154327","volume":"243","author":"APC Ruano","year":"2023","unstructured":"Ruano, A. P. C. et al. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus. Pathol. Res. Pract. 243, 154327 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"69984_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fonc.2020.00505","volume":"10","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y. et al. Next generation sequencing assay for detection of circulating HPV DNA (cHPV-DNA) in patients undergoing radical (chemo)radiotherapy in anal squamous cell carcinoma (ASCC). Front. Oncol. 10, 505 (2020).","journal-title":"Front. Oncol."},{"key":"69984_CR20","doi-asserted-by":"publisher","unstructured":"Huffman, B. M. et al. Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. J. Immunother. Cancer 12, https:\/\/doi.org\/10.1136\/jitc-2023-008436 (2024).","DOI":"10.1136\/jitc-2023-008436"},{"key":"69984_CR21","doi-asserted-by":"publisher","unstructured":"Andrioaie, I. M. et al. The clinical utility of circulating HPV DNA biomarker in oropharyngeal, cervical, anal, and skin HPV-related cancers: a review. Pathogens 12, https:\/\/doi.org\/10.3390\/pathogens12070908 (2023).","DOI":"10.3390\/pathogens12070908"},{"key":"69984_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jamaoncol.2024.1821","volume":"10","author":"NY Lee","year":"2024","unstructured":"Lee, N. Y., Morris, L. G. T. & Diehn, M. Assessing the evidence for circulating tumor HPV DNA in patients with oropharyngeal cancer. JAMA Oncol. 10, 1021\u20131022 (2024).","journal-title":"JAMA Oncol."},{"key":"69984_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1055968","volume":"12","author":"HT Chan","year":"2022","unstructured":"Chan, H. T. et al. Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients. Front. Oncol. 12, 1055968 (2022).","journal-title":"Front. Oncol."},{"key":"69984_CR24","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216505","volume":"15","author":"A Santonja","year":"2023","unstructured":"Santonja, A. et al. Comparison of tumor-informed and tumor-naive sequencing assays for ctDNA detection in breast cancer. EMBO Mol. Med. 15, e16505 (2023).","journal-title":"EMBO Mol. Med."},{"key":"69984_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.radonc.2020.06.045","volume":"150","author":"AC Lefevre","year":"2020","unstructured":"Lefevre, A. C. et al. Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence. Radiother. Oncol. 150, 211\u2013216 (2020).","journal-title":"Radiother. Oncol."},{"key":"69984_CR26","first-page":"128","volume":"26","author":"E Malusecka","year":"2022","unstructured":"Malusecka, E., Giglok, M., Suwinski, R., Rutkowski, T. W. & Mazurek, A. M. Quantitative analysis of plasma DNA in anal cancer patients. Contemp. Oncol. 26, 128\u2013132 (2022).","journal-title":"Contemp. Oncol."},{"key":"69984_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/oncolo\/oyac249","volume":"28","author":"G Azzi","year":"2023","unstructured":"Azzi, G. et al. Using tumor-informed circulating tumor DNA (ctDNA)-based testing for patients with anal squamous cell carcinoma. Oncologist 28, 220\u2013229 (2023).","journal-title":"Oncologist"},{"key":"69984_CR28","doi-asserted-by":"publisher","unstructured":"Kabarriti, R. et al. Evaluating tumor tissue modified viral (TTMV)-HPV DNA for the early detection of anal squamous cell carcinoma recurrence. Cancers 17, https:\/\/doi.org\/10.3390\/cancers17020174 (2025).","DOI":"10.3390\/cancers17020174"},{"key":"69984_CR29","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-25-0421","volume":"31","author":"A Bercz","year":"2025","unstructured":"Bercz, A., Faden, D. L., Smith, J. J. & Romesser, P. B. Clocking recurrence: circulating tumor HPV DNA kinetics in anal cancer. Clin. Cancer Res. 31, 2261\u20132263 (2025).","journal-title":"Clin. Cancer Res."},{"key":"69984_CR30","unstructured":"American Joint Committee on Cancer (AJCC) 8th edn (Springer, 2017)."},{"key":"69984_CR31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaoncol.2019.0528","volume":"5","author":"T Reinert","year":"2019","unstructured":"Reinert, T. et al. Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer. JAMA Oncol. 5, 1124\u20131131 (2019).","journal-title":"JAMA Oncol."},{"key":"69984_CR32","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1158\/1078-0432.CCR-18-3663","volume":"25","author":"RC Coombes","year":"2019","unstructured":"Coombes, R. C. et al. Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence. Clin. Cancer Res. 25, 4255\u20134263 (2019).","journal-title":"Clin. Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69984-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69984-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69984-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:18:05Z","timestamp":1775650685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69984-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69984"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69984-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Romesser provides compensated professional services and activities for EMD Serono, Faeth Therapeutics, HPV Alliance, and Natera Inc. He also offers uncompensated professional services and activities for 10x Genomics, XRad Therapeutics, and the HPV Alliance and Anal Cancer Foundation non-profit organizations. Dr. Smith received travel support for fellow education from Intuitive Surgical (August 2015). He also served as a clinical advisor for Guardant Health (March 2019). He provides compensated professional services and activities for Johnson and Johnson, GlaxoSmithKline, Foundation Medicine, UroGen, Regeneron, and Vaniam Group. Dr. Garcia-Aguilar owns equity and received honoraria from Intuitive Surgical. Dr. Weiser owns intellectual property rights and provides compensated professional services for UpToDate. Dr. Cercek owns equity in Haystack Oncology, Inc. She also provides compensated professional services for AbbVie, Agenus, Amen, Daiichi Sankyo, GlaxoSmithKline, Illumina, Janssen Oncology, Inc., Merck & Co. Inc., Regeneron Pharmaceuticals, Inc., Roche Diagnostics Asia Pacific Ltd., and Seagen. Dr. Crane owns equity in Oncternal Therapeutics and provides compensated professional services for Trisalus Life Sciences. Dr. Segal provides compensated professional services for Puretech Health, Regeneron Pharmaceuticals Inc., and Agenus Inc. Dr. Reyngold provides compensated professional services and activities for Elekta and offer uncompensated professional services for the National Comprehensive Cancer Network. Dr. Yaeger provides compensated professional services and activities for Lilly Oncology, Mirati Therapeutics, Revolution Medicines, and Merck. Dr. Wu provides compensated professional services and activities for CivaTech Oncology, Inc., MORE Health, Inc., Nanovi A\/S, and Simphotek, Inc. Dr. Connell provides compensated professional services and activities for Intera Oncology, Inc. Dr. Rao owns equity in Abbott Laboratories, CVS Health Corp., GlaxoSmithKline, Merck & Co., Novartis Pharmaceuticals Corporation, Procter & Gamble, Sandoz, Inc., Sanofi-Aventis U.S. LLC, and UnitedHealth Group. Drs. Aushev, Sharma, Malhotra, Rivero-Hinojosa, Jurdi, and Liu are employees of Natera, Inc. and receive equity in the company. All other authors do not have any conflicts of interest to disclose. Role of Natera: Natera, Inc. generated the personalized ctDNA assays and performed bioinformatic variant calling; Natera staff assisted with generation of Figs.\u00a0\n                      \n                      B,\n                      \n                      , and\n                      \n                      . All clinical endpoints and outcome analyses were performed independently at MSK by institutional statisticians; patient management and outcome adjudication were conducted independent of the company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3241"}}